AEGON Asset Management (UK)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 156 |
|
2023
Q1 | $4K | Buy |
45
+6
| +15% | +$533 | ﹤0.01% | 158 |
|
2022
Q4 | $3K | Sell |
39
-16,588
| -100% | -$1.28M | ﹤0.01% | 161 |
|
2022
Q3 | $1.38M | Buy |
16,627
+16,588
| +42,533% | +$1.37M | 0.03% | 141 |
|
2022
Q2 | $4K | Buy |
+39
| New | +$4K | ﹤0.01% | 167 |
|
2020
Q3 | – | Sell |
-35,337
| Closed | -$2.44M | – | 152 |
|
2020
Q2 | $2.44M | Hold |
35,337
| – | – | 0.05% | 110 |
|
2020
Q1 | $2.22M | Hold |
35,337
| – | – | 0.06% | 102 |
|
2019
Q4 | $2.75M | Hold |
35,337
| – | – | 0.07% | 111 |
|
2019
Q3 | $2.59M | Hold |
35,337
| – | – | 0.07% | 104 |
|
2019
Q2 | $2.18M | Hold |
35,337
| – | – | 0.06% | 108 |
|
2019
Q1 | $2.25M | Hold |
35,337
| – | – | 0.06% | 96 |
|
2018
Q4 | $1.8M | Sell |
35,337
-11,154
| -24% | -$569K | 0.06% | 103 |
|
2018
Q3 | $2.7M | Hold |
46,491
| – | – | 0.06% | 97 |
|
2018
Q2 | $2.26M | Hold |
46,491
| – | – | 0.06% | 106 |
|
2018
Q1 | $2.16M | Sell |
46,491
-8,181
| -15% | -$380K | 0.06% | 112 |
|
2017
Q4 | $2.05M | Hold |
54,672
| – | – | 0.05% | 113 |
|
2017
Q3 | $1.99M | Buy |
54,672
+20,631
| +61% | +$752K | 0.05% | 106 |
|
2017
Q2 | $1.34M | Sell |
34,041
-1,041
| -3% | -$41K | 0.04% | 130 |
|
2017
Q1 | $1.1M | Sell |
35,082
-552
| -2% | -$17.3K | 0.03% | 166 |
|
2016
Q4 | $1.11M | Sell |
35,634
-1,884
| -5% | -$58.8K | 0.03% | 150 |
|
2016
Q3 | $1.51M | Buy |
+37,518
| New | +$1.51M | 0.04% | 113 |
|
2015
Q2 | – | Sell |
-64,074
| Closed | -$1.52M | – | 193 |
|
2015
Q1 | $1.52M | Buy |
+64,074
| New | +$1.52M | 0.04% | 131 |
|